Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.
2.

Chemosensitivity testing--present and future in Japan.

Kubota T, Otani Y, Furukawa T, Hasegawa H, Watanabe M, Kitajima M.

Recent Results Cancer Res. 2003;161:231-41.

PMID:
12528811
3.

Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer.

Iwahashi M, Nakamori M, Nakamura M, Noguchi K, Ueda K, Nakatani Y, Ojima T, Ishida K, Naka T, Yamaue H.

Anticancer Res. 2005 Sep-Oct;25(5):3453-9.

4.

Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination.

Kubota T, Egawa T, Otani Y, Furukawa T, Saikawa Y, Yoshida M, Watanabe M, Kumai K, Kitajima M.

Anticancer Res. 2003 Jan-Feb;23(1B):583-7.

PMID:
12680150
5.

[Gastric cancer: laparoscopic surgery and adjuvant chemotherapy].

Tanigawa N.

Nihon Geka Gakkai Zasshi. 2004 Sep;105(9):489-93. Review. Japanese.

PMID:
15500091
6.

Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.

[No authors listed]

Prescrire Int. 2013 May;22(138):122.

PMID:
23819172
7.

Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.

Meng C, Lu Z, Fang M, Zhou X, Dai K, Zhang S, Luo J, Luo Z.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):7622-32. eCollection 2014.

8.

Chemotherapy for advanced gastric cancer.

Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, Ho J, Unverzagt S.

Cochrane Database Syst Rev. 2017 Aug 29;8:CD004064. doi: 10.1002/14651858.CD004064.pub4. Review.

PMID:
28850174
9.

Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively.

Maejima K, Tokunaga A, Kiyama T, Kanno H, Bou H, Watanabe M, Suzuki H, Uchida E.

Gastric Cancer. 2010 Nov;13(4):231-7. doi: 10.1007/s10120-010-0564-1. Epub 2010 Dec 3.

PMID:
21128058
10.

[Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].

Wan Y, Hui H, Wang X, Wu J, Sun S.

Zhonghua Zhong Liu Za Zhi. 2016 Jan;38(1):28-34. doi: 10.3760/cma.j.issn.0253-3766.2016.01.006. Chinese.

PMID:
26796803
11.

Chemosensitivity testing for gastrointestinal cancer: survival benefit potential and limitations.

Kim R, Emi M, Tanabe K, Uchida Y, Toge T.

Anticancer Drugs. 2003 Oct;14(9):715-23. Review.

PMID:
14551504
13.

Adjuvant therapy of gastric cancer: the Japanese experience.

Fukushima M.

Semin Oncol. 1996 Jun;23(3):369-78. Review.

PMID:
8658221
14.

[A case of advanced gastric cancer responding remarkably to neo-adjuvant combination chemotherapy using CPT-11 plus S-1].

Saze Z, Terashima M, Otani S, Soeta N, Kashimura S, Osuka F, Odashima Y, Saito T, Hoshino Y, Kogure M, Hashimoto Y, Watanabe K, Gotoh M.

Gan To Kagaku Ryoho. 2007 Sep;34(9):1473-6. Japanese.

PMID:
17876149
15.

[Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].

Sakurai Y, Kamoshida S, Furuta S, Sunagawa R, Inaba K, Isogaki J, Komori Y, Uyama I, Tsutsumi Y.

Gan To Kagaku Ryoho. 2008 Jul;35(7):1147-55. Japanese.

PMID:
18633253
16.

[Present state and prospects of adjuvant chemotherapy for gastric cancer].

Hori T, Ozawa R, Hanayama H, Yamashita H, Kaibe N, Matsumoto T, Oshima T, Takemura M, Kikuchi S, Sasako M.

Gan To Kagaku Ryoho. 2011 Sep;38(9):1390-5. Japanese.

PMID:
21918333
17.

New chemotherapy strategies for gastric cancer.

Kubota T.

In Vivo. 2008 May-Jun;22(3):273-8. Review.

18.

Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancers.

Abe S, Kubota T, Matsuzaki SW, Otani Y, Watanabe M, Teramoto T, Kumai K, Kitajima M.

Anticancer Res. 1999 Sep-Oct;19(5C):4581-6.

PMID:
10650814
19.

Adjuvant and neoadjuvant therapy for gastric cancer.

Kelsen DP.

Semin Oncol. 1996 Jun;23(3):379-89. Review.

PMID:
8658222
20.

[The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].

Ausch C, Rosen HR, Schiessel R.

Wien Klin Wochenschr. 1996;108(16):496-504. Review. German.

PMID:
8967093

Supplemental Content

Support Center